Latest Commercialisation News

American Rare Earths has installed groundwater monitoring wells at its Cowboy State Mine, advancing environmental permitting and keeping its rare earth project on track for 2029 production.

ReNerve Limited has gained marketing approval for its NervAlign® Nerve Cuff™ in Bahrain, marking its first regulatory success in the Middle East and opening access to a rapidly expanding regional market.

Aurora Labs has signed a Memorandum of Understanding with Mayman Aerospace to jointly develop 3D-printed micro gas turbines for advanced VTOL aircraft, marking its strategic entry into the U.S. aerospace sector.

Finder Energy has completed a landmark reprocessing of its Ikan 3D seismic data, delivering enhanced imaging that sharpens development plans for the Kuda Tasi and Jahal oil fields. This technical leap forward accelerates the path toward first oil and unlocks new exploration potential within the PSC 19-11 permit.

Neuren Pharmaceuticals posted record 2024 financials driven by DAYBUE royalties and advanced NNZ-2591 into Phase 3 trials, while launching a $50 million share buy-back amid volatile market sentiment.

Lumos Diagnostics has secured Medicare reimbursement for its FebriDx test from a sixth Medicare Administrative Contractor, covering over 85% of US Medicare payment regions. This milestone advances the company’s commercialisation efforts in the US healthcare market.

Future Battery Minerals Ltd has identified significant gold mineralisation at its Miriam Project in Western Australia, setting the stage for a targeted drilling campaign in July 2025. The company’s review of historical data highlights multiple high-potential prospects, including the Forrest zone with continuous gold intercepts over 600 metres.

Solstice Minerals has delivered promising first-ever Reverse Circulation drilling results at its Edjudina Range gold discovery in Western Australia, confirming significant gold mineralisation and setting the stage for accelerated exploration.

Brazilian Critical Minerals has achieved a significant breakthrough in its Ema rare earths project by demonstrating rapid hydraulic permeability using in-situ recovery techniques, a crucial step towards commercial mining.

Orbital Corporation has appointed Stephen Pearce as CEO, marking a strategic shift from engine development to commercialising propulsion and flight management systems for defence UAVs.

OncoSil Medical has launched a $8.7 million capital raising via a Share Purchase Plan and Placement, seeking shareholder approval for options issuance and a 400:1 share consolidation.

Bass Oil Limited reported steady April production and a strategic acquisition of the Vanessa gas field, positioning itself for future gas market entry.